Walleye Trading’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Walleye Trading’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$2.56K	–	5684
2022 Q4	$2.56K	Hold	40,000	–	–	﹤0.01%	4690
2022 Q3	$2K	Hold	40,000	–	–	﹤0.01%	4843
2022 Q2	$4K	Hold	40,000	–	–	﹤0.01%	4859
2022 Q1	$10K	Hold	40,000	–	–	﹤0.01%	4963
2021 Q4	$26K	Buy	+40,000	New	+$27.7K	﹤0.01%	4858

Walleye Trading's BIOTW Position: Q1 2023 in Review

Walleye Trading sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 40,000 shares — an estimated $2.56K sold.

Walleye Trading first reported a position in BIOTW in Q4 2021 and held it in 5 quarters. The position peaked at $26K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

Walleye Trading reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 40,000 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $2.56K.
Walleye Trading first reported a position in Biotech Acquisition Company Warrant in Q4 2021 and held it in 5 quarters.
Walleye Trading's Biotech Acquisition Company Warrant position peaked at $26K in Q4 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.